Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Page 1
Added value and clinical impact of second-opinion subspecialist radiologist interpretations of baseline rectal MRI in patients with rectal cancer.
Golia Pernicka JS, Kim TH, Nougaret S, Bates DDB, El Homsi M, Louis Fuqua J 3rd, Gangai N, Horvat N, Pappou E, Paroder V, Widmar M, Petkovska I, Gollub MJ. Golia Pernicka JS, et al. Among authors: paroder v. Eur Radiol. 2025 Nov 14:10.1007/s00330-025-12132-9. doi: 10.1007/s00330-025-12132-9. Online ahead of print. Eur Radiol. 2025. PMID: 41236658 Free PMC article.
Identifying baseline rectal MRI features as predictive indicators for local recurrence and metastatic disease in rectal cancer treated with surgical resection and neoadjuvant therapy or surgical resection alone.
El Homsi M, Javed-Tayyab S, Charbel C, Golia Pernicka JS, Paroder V, White C, Capanu M, Rodriguez L, Gangai N, Petkovska I. El Homsi M, et al. Among authors: paroder v. Eur J Radiol. 2025 Jul;188:112152. doi: 10.1016/j.ejrad.2025.112152. Epub 2025 May 1. Eur J Radiol. 2025. PMID: 40319786
Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case report.
Mourad M, Al Mahmasani L, Abbas N, Sainamthip P, Freile B, Zayed A, Alsuwailem R, Khatib O, Sinno S, Sabatin F, Shia J, Kreidieh F, Paroder V, Alam S, Shamseddine A, Abou-Alfa GK. Mourad M, et al. Among authors: paroder v. J Gastrointest Oncol. 2024 Dec 31;15(6):2712-2720. doi: 10.21037/jgo-24-359. Epub 2024 Dec 24. J Gastrointest Oncol. 2024. PMID: 39816020 Free PMC article.
Watch & wait - Post neoadjuvant imaging for rectal cancer.
El Homsi M, Bercz A, Chahwan S, Fernandes MC, Javed-Tayyab S, Golia Pernicka JS, Nincevic J, Paroder V, Ruby L, Smith JJ, Petkovska I. El Homsi M, et al. Among authors: paroder v. Clin Imaging. 2024 Jun;110:110166. doi: 10.1016/j.clinimag.2024.110166. Epub 2024 Apr 21. Clin Imaging. 2024. PMID: 38669916 Free PMC article. Review.
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, Srivastava A, Tang LH, Schoder H, Janjigian YY. Cytryn SL, et al. Among authors: paroder v. J Nucl Med. 2024 May 1;65(5):722-727. doi: 10.2967/jnumed.123.267186. J Nucl Med. 2024. PMID: 38514081 Free PMC article.
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL, Moy RH, Cowzer D, Shah RH, Chou JF, Joshi SS, Ku GY, Maron SB, Desai A, Yang J, Sugarman R, Rao D, Goldberg Z, Charalambous C, Lapshina M, Antoine A, Socolow F, Trivedi N, Capanu M, Gerdes H, Schattner MA, Simmons M, Lacouture ME, Paroder V, Tang LH, Shia J, Ilson DH, Solit DB, Berger MF, Janjigian YY. Cytryn SL, et al. Among authors: paroder v. Lancet Oncol. 2023 Oct;24(10):1073-1082. doi: 10.1016/S1470-2045(23)00358-3. Epub 2023 Sep 1. Lancet Oncol. 2023. PMID: 37666264 Free PMC article. Clinical Trial.
70 results